←Back to Expert Scholars
Translational Medicine / 转化医学Checkpoint Combinations, Melanoma
Jeffrey Sosman
MD
🏢Northwestern University Feinberg School of Medicine🌐USA
Professor of Medicine
80
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Jeffrey Sosman is a melanoma immunotherapy leader at Northwestern who has participated in pivotal BRAF inhibitor and checkpoint blockade trials. He has contributed to studies of sequential and combination targeted and immune therapy. His work informs modern melanoma treatment algorithms.
Share:
🧪Research Fields 研究领域
melanoma immunotherapy
BRAF and immunotherapy combinations
ipilimumab nivolumab
checkpoint combinations
translational melanoma research
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Jeffrey Sosman 的研究动态
Follow Jeffrey Sosman's research updates
留下邮箱，当我们发布与 Jeffrey Sosman（Northwestern University Feinberg School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment